Later, in October 2001, Robert Nicholson’s group [12] reported the discovery and characterization of TENB2 while attempting to identify differentially expressed genes between androgen-dependent and androgen-independent stages of prostate cancer using the TEN12 prostate cancer xenograft model. Here, TMEFF2 is linked to prostate cancer.